| Multiple organ failure - death of consumer protection? | |
| | |
MedLine Citation:
|
PMID: 20822613 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The enormously profitable complementary medicines, dietary supplements and traditional medicines markets are largely unregulated internationally and South Africa. Attempts to ensure that consumers are not exposed to harmful or ineffective products have met with varying success around the world. |
| | |
Authors:
|
H A Steinman; M R Jobson |
Related Documents
:
|
9853353 - Quality assurance in renography: a review. 1943163 - Plants used in traditional medicine in eastern tanzania. v. angiosperms (passifloraceae... 21897643 - Why and how? addressing to the two most pertinent questions about pharmacovigilance in ... |
Publication Detail:
|
Type: Journal Article Date: 2010-07-15 |
Journal Detail:
|
Title: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Volume: 100 ISSN: 0256-9574 ISO Abbreviation: S. Afr. Med. J. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-09-08 Completed Date: 2010-10-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0404520 Medline TA: S Afr Med J Country: South Africa |
Other Details:
|
Languages: eng Pagination: 494-7 Citation Subset: IM |
Affiliation:
|
Allergy Society of South Africa. harris@zingsolutions.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Advertising as Topic
/
legislation & jurisprudence Complementary Therapies / legislation & jurisprudence* Consumer Product Safety / legislation & jurisprudence* Dietary Supplements / standards* Legislation, Pharmacy / standards Medicine, Traditional / standards* Pharmaceutical Preparations / standards South Africa |
| Chemical | |
Reg. No./Substance:
|
0/Pharmaceutical Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Approval of chronic medication - Discovery Health hits new lows.
Next Document: Requiem for Babinski.